Cogent Biosciences Statistics
Total Valuation
COGT has a market cap or net worth of $661.02 million. The enterprise value is $446.68 million.
Important Dates
The next estimated earnings date is Tuesday, May 6, 2025, before market open.
Earnings Date | May 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
COGT has 110.54 million shares outstanding. The number of shares has increased by 30.36% in one year.
Current Share Class | 110.46M |
Shares Outstanding | 110.54M |
Shares Change (YoY) | +30.36% |
Shares Change (QoQ) | +1.17% |
Owned by Insiders (%) | 0.04% |
Owned by Institutions (%) | 74.27% |
Float | 69.99M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 4.92 |
P/TBV Ratio | 4.92 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.32, with a Debt / Equity ratio of 0.07.
Current Ratio | 5.32 |
Quick Ratio | 5.15 |
Debt / Equity | 0.07 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -99.54% and return on invested capital (ROIC) is -62.67%.
Return on Equity (ROE) | -99.54% |
Return on Assets (ROA) | -53.78% |
Return on Invested Capital (ROIC) | -62.67% |
Return on Capital Employed (ROCE) | -101.38% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.25M |
Employee Count | 205 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -10.86% in the last 52 weeks. The beta is 0.08, so COGT's price volatility has been lower than the market average.
Beta (5Y) | 0.08 |
52-Week Price Change | -10.86% |
50-Day Moving Average | 7.83 |
200-Day Moving Average | 9.17 |
Relative Strength Index (RSI) | 33.15 |
Average Volume (20 Days) | 1,061,596 |
Short Selling Information
The latest short interest is 11.84 million, so 10.71% of the outstanding shares have been sold short.
Short Interest | 11.84M |
Short Previous Month | 11.66M |
Short % of Shares Out | 10.71% |
Short % of Float | 16.91% |
Short Ratio (days to cover) | 9.77 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -275.94M |
Pretax Income | -227.05M |
Net Income | -255.86M |
EBITDA | -273.49M |
EBIT | -275.94M |
Earnings Per Share (EPS) | -$2.46 |
Full Income Statement Balance Sheet
The company has $287.08 million in cash and $17.47 million in debt, giving a net cash position of $269.61 million or $2.44 per share.
Cash & Cash Equivalents | 287.08M |
Total Debt | 17.47M |
Net Cash | 269.61M |
Net Cash Per Share | $2.44 |
Equity (Book Value) | 256.29M |
Book Value Per Share | 1.32 |
Working Capital | 240.76M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$207.79 million and capital expenditures -$573,000, giving a free cash flow of -$208.36 million.
Operating Cash Flow | -207.79M |
Capital Expenditures | -573,000 |
Free Cash Flow | -208.36M |
FCF Per Share | -$1.88 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |